Walleye Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,413
| Closed | -$1.43M | – | 3162 |
|
|
2023
Q4 | $1.43M | Buy |
+24,413
| New | +$1.43M | ﹤0.01% | 760 |
|
|
2023
Q3 | – | Sell |
-39,564
| Closed | -$1.43M | – | 3143 |
|
|
2023
Q2 | $1.43M | Sell |
39,564
-142,916
| -78% | -$5.16M | 0.01% | 614 |
|
|
2023
Q1 | $6.78M | Buy |
182,480
+140,382
| +333% | +$5.22M | 0.1% | 219 |
|
|
2022
Q4 | $1.91M | Buy |
+42,098
| New | +$1.91M | 0.03% | 491 |
|
|
2022
Q2 | – | Sell |
-2,691
| Closed | -$221K | – | 2729 |
|
|
2022
Q1 | $221K | Sell |
2,691
-18,405
| -87% | -$1.51M | 0.01% | 1415 |
|
|
2021
Q4 | $3.1M | Buy |
+21,096
| New | +$3.1M | 0.1% | 223 |
|
|
2020
Q1 | – | Sell |
-4,462
| Closed | -$575K | – | 1033 |
|
|
2019
Q4 | $575K | Buy |
+4,462
| New | +$575K | 0.04% | 162 |
|
|
2019
Q3 | – | Sell |
-820
| Closed | -$84K | – | 1085 |
|
|
2019
Q2 | $84K | Buy |
+820
| New | +$84K | 0.01% | 276 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 651 |
|